Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index; 21 of the 42 sources its claims cite were checked for support.
Abstract
Cellular senescence, a stress-induced irreversible growth arrest often characterized by expression of p16(Ink4a) (encoded by the Ink4a/Arf locus, also known as Cdkn2a) and a distinctive secretory phenotype, prevents the proliferation of preneoplastic cells and has beneficial roles in tissue remodelling during embryogenesis and wound healing. Senescent cells accumulate in various tissues and organs over time, and have been speculated to have a role in ageing. To explore the physiological relevance and consequences of naturally occurring senescent cells, here we use a previously established transgene, INK-ATTAC, to induce apoptosis in p16(Ink4a)-expressing cells of wild-type mice by injection of AP20187 twice a week starting at one year of age. We show that compared to vehicle alone, AP20187 treatment extended median lifespan in both male and female mice of two distinct genetic backgrounds. The clearance of p16(Ink4a)-positive cells delayed tumorigenesis and attenuated age-related deterioration of several organs without apparent side effects, including kidney, heart and fat, where clearance preserved the functionality of glomeruli, cardio-protective KATP channels and adipocytes, respectively. Thus, p16(Ink4a)-positive cells that accumulate during adulthood negatively influence lifespan and promote age-dependent changes in several organs, and their therapeutic removal may be an attractive approach to extend healthy lifespan.
Overview
CoChat Summary
TL;DR
Clearance of naturally occurring p16Ink4a-positive senescent cells in non-progeroid INK-ATTAC mice starting at 12 months of age extended median lifespan and delayed multiple age-related pathologies. The authors conclude that p16Ink4a-positive cells that accumulate during adulthood negatively influence lifespan and promote age-dependent changes in several organs.
Key findings
- AP20187 treatment extended median lifespan in both sexes and two genetic backgrounds: mixed-background mice by 27% and C57BL/6 mice by 24% when sexes were combined; sex-specific median lifespan increases ranged from 17% to 35%. Maximum lifespan was significantly increased only for mixed AP-treated males and females combined (p = 0.0295), not for C57BL/6 mice or individual sexes.
- Clearance delayed tumorigenesis and increased tumor latency without changing the incidence or spectrum of macroscopically detectable tumors at autopsy; median lifespan extension among AP-treated mice dying without tumors ranged from 24% to 42%.
- Clearance attenuated age-related deterioration in fat, kidney, heart, and eye: it prevented fat mass loss and adipogenesis marker declines, reduced glomerulosclerosis and blood urea nitrogen increases, reduced cardiomyocyte hypertrophy and preserved cardiac stress tolerance, and delayed cataract formation. It also prevented age-dependent reductions in spontaneous activity and exploratory behavior.
- Clearance was partial and tissue selective: p16Ink4a-positive cells were reduced in most tissues examined but not colon or liver. In iWAT, AP-treated mice had 8-fold fewer GFP+ adipocyte progenitors; X-Gal crystal-containing cells were 0.2% vs 1.6% in iWAT and 0.3% vs 1.2% in kidney for AP-treated vs untreated mice, respectively.
Methods
- Two consecutive cohorts of INK-ATTAC transgenic mice were injected twice weekly with AP20187 or vehicle beginning at 12 months of age until moribund or death. The first cohort was on a mixed 129Sv × C57BL/6J × FVB background fed a 9% fat diet; the second was on a congenic C57BL/6J background fed a 5% fat diet. Dosing was 0.2 μg AP20187/g body weight between 12 and 18 months and 2.0 μg/g thereafter in the mixed cohort, and 2.0 μg/g from 12 months in the C57BL/6J cohort.
- Lifespan was analyzed with survival curves and log-rank tests; maximum lifespan was tested with two-sided Wang-Allison tests. Healthspan analyses at 18 months included qRT-PCR for senescence and inflammation markers, FACS, SAβ-Gal staining, TEM with X-ray elemental analysis, echocardiography, cardiac stress tests, metabolic and behavioral assays, and histology.
- The paper states that no power calculations were used; sample sizes were based on previously published experiments where differences were observed. Investigators were blinded to allocation during experiments and outcome assessment except for rare instances where blinding was not possible.
Limitations
- The authors state that clearance was partial and several key tissues were refractory, including liver and colon; they note that further optimization of senescent cell removal protocols is needed.
- The authors state that repetitive vehicle injection stress may have negatively impacted longevity of male C57BL/6 mice, and that maximum lifespan was not extended in C57BL/6 AP-treated animals.
- The authors state that their limited analyses do not exclude the possibility that other p16Ink4a-positive non-senescent cells engage ATTAC and die upon AP exposure; they also note that no power calculations were used.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
8 Valid · 5 Not valid · 8 Not checked · 114 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Earlier we have shown that, in BubR1 progeroid mice, ATTAC ablates p16 Ink4a -positive senescent cells upon administration of AP20187 (AP), a dimerizer that activates FKBP-fused Casp8 4 .”
What the sources say
- Supportedcites [4] 4. Baker DJ, et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature. 2011; 479:232-236. [PubMed: 22048312] source
In the main text (Fig. 3a–e), AP20187-treated BubR1H/H;INK-ATTAC mice show reduced senescence markers, which the authors interpret as clearance of senescent cells. The Methods ('Mouse strains and drug treatments') identifies AP20187 as the dimer-inducing drug, and the main text describes activation of the FKBP–Casp8 fusion protein by AP20187. (LLM, conf=0.94)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“ATTAC was also not induced in peripheral blood T lymphocytes that robustly engage endogenous p16 Ink4a with aging without concomitant expression of multiple senescence markers 2 , 13 (Extended Data Fig. 2h), further implying that transgene induction is quite selective for senescence.”
What the sources say
- Not checked — no full text of the sourcecites [2] 2. Sharpless NE, Sherr CJ. Forging a signature of in vivo senescence. Nat Rev Cancer. 2015; 15:397408. [PubMed: 26105537] source
- Partly supportedcites [13] 13. Liu Y, et al. Expression of p16(INK4a) in peripheral blood T-cells is a biomarker of human aging. Aging Cell. 2009; 8:439-448. [PubMed: 19485966] sourceExperimental — accuracy not yet measured
The section ‘Increased p16 INK4a expression is associated with chronological age’ reports that p16 INK4a expression in peripheral blood T lymphocytes increases with age (page unavailable). It does not address ATTAC induction or establish whether those cells express multiple senescence markers, so it supports only the aging-related p16 portion of the attributed claim. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“When AP was administered during wound closure, healing was delayed with similar kinetics as 4- or 18-month-old ATTAC mice without prior AP treatment, indicating that acute senescence mechanisms are preserved with aging and not influenced by constitutive clearance of senescent cells 3 .”
What the sources say
- Could not verifycites [3] 3. van Deursen JM. The role of senescent cells in ageing. Nature. 2014; 509:439-446. [PubMed: 24848057] sourceExperimental — accuracy not yet measured
The 'Senescence in ageing and age-related disease' section says AP20187 was used to eliminate senescent cells in INK-ATTAC mice. The 'Acute versus chronic senescence' section discusses senescence during wound closure, but neither section reports AP administration during wound closure, delayed healing, or a comparison with untreated 4- or 18-month-old mice. Pages were not provided in our copy. (LLM, conf=0.76)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Consistent with a beneficial role of senescent cells only for the duration of wound repair 6 - 8 , 18-month-old AP-treated ATTAC mice repaired cutaneous wounds when drug administration was suspended during healing (Extended Data Fig. 10ac).”
What the sources say
- Could not verifycites [6] 6. Jun JI, Lau LF. The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol. 2010; 12:676-685. [PubMed: 20526329] sourceExperimental — accuracy not yet measured
The Methods (Animals and cutaneous wound healing) describe 12-week-old Ccn1 mice, and the Results report wound healing in those mice. Our copy does not report 18-month-old ATTAC mice, AP treatment, or suspension of treatment during healing. In the citing sentence, this citation appears to support the preceding background point about senescent cells in wound repair; the ATTAC observation is presented as the citing authors’ own Extended Data result. (LLM, conf=0.78)
- Could not verifycites [7] 7. Krizhanovsky V, et al. Senescence of activated stellate cells limits liver fibrosis. Cell. 2008; 134:657-667. [PubMed: 18724938] sourceExperimental — accuracy not yet measured
The Animals and Results sections describe mice studied for liver fibrosis, not AP-treated ATTAC mice or cutaneous wound repair. The Discussion suggests that senescence may be relevant to other wound-healing responses, but our copy does not report the specific wound-healing observation; I searched for cutaneous wound repair and senescence. (LLM, conf=0.78)
- Partly supportedcites [8] 8. Demaria M, et al. An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA. Dev Cell. 2014; 31:722-733. [PubMed: 25499914] sourceExperimental — accuracy not yet measured
The Results section ('Elimination of Senescent Cells Delays Cutaneous Wound Healing'; page unavailable) reports that senescent cells facilitate cutaneous wound repair. The Experimental Procedures ('Mice'; page unavailable) describe p16-3MR mice treated with GCV, not 18-month-old ATTAC mice treated with AP. Our copy does not report wound repair after AP administration was suspended during healing. (LLM, conf=0.84)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Clearance had no impact on the spectrum or incidence of postmortem tumors, which is consistent with the hypothesis that senescent cells help create a tissue microenvironment that promotes tumor progression 1 .”
What the sources say
- Could not verifycites [1] 1. Campisi J. Aging, cellular senescence, and cancer. Annual review of physiology. 2013; 75:685-705. sourceExperimental — accuracy not yet measured
The Senescent Cells and Cancer section discusses how senescent cells can promote tumor growth, but it does not report whether clearing them changed the spectrum or incidence of postmortem tumors. The Immune Clearance section discusses clearance by immune cells, not postmortem tumor outcomes. Searches for postmortem tumors and tumor incidence after clearance found no passage addressing that result. (LLM, conf=0.76)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
83 more claims
Create a free account to see all 135 claims and every source verdict.
- Probably not a substantial claim. 24
- It may state two separate claims as one. 25
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“The expression of p16Ink4a is essentially undetectable in young and healthy tissues, but p16Ink4a+ cells accumulate in many aged or diseased tissues.18,19,21,22,23,28”
From Identifying specific functional roles for senescence across cell types (2024) · doi:10.1016/j.cell.2024.09.021 · cites this paper as [28]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Ablating p16+ cells in these mice suppresses age-related disease, extending the health span of two independent strains of transgenic mice: INK-ATTAC and p16-3MR (see Supplemental Figure 1 for a description of the models) (8–10).”
From Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span (2021) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“AP20187, a molecule that induces apoptosis in p16INK4a-expressing cells8”
From Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment (2017) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“supporting the notion that senescent cells progressively accumulate in the organism during aging at previously described rates for mice30.”
From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Glomerular endothelial cells140 and proximal tubular epithelial cells (TECs)140,141 become senescent with ageing in mice, showing increased SA-β-gal staining and Cdkn2a expression.”
From SenNet recommendations for detecting senescent cells in different tissues (2024) · cites this paper as [141]
Experimental — accuracy not yet measured
77 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Statistical analysis
“For consistency in these comparisons, the following denotes significance in all figures: * P < 0.05, ** P < 0.01 and *** P < 0.001.”
§ Extended Data
“Log-rank tests were used to determine statistical significance. *, P<0.01; ** P<0.001; ***, P<0.001.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Mouse strains and drug treatments
“Mice from this cohort were randomly assigned to be injected with AP20187 (B/B homodimerizer, Clontech, Mountain View, CA, USA) or vehicle twice a week beginning at 12 months of age.”
§ Mouse strains and drug treatments
“Dosing was 0.2 μg AP20817/g body weight between 12 and 18 months (the same dose as previously used for senescent cell clearance in BubR1 progeroid mice; see reference 4), and 2.0 μg AP20187/g body weight from thereon.”
Citations
Cites
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 8×
“ATTAC MEFs were generated as previously described 4 .”
InfluentialSelf-citationAging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954
The role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623 · cited 2×
“All studies described using ATTAC mice were performed on transgenic line 3, which contains 13 copies of the transgene inserted into a single locus (data available upon request).”
Cellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363 · cited 1×
“…p16 Ink4a -positive cells is not associated with any overt detrimental effects raise the possibility that this approach may be useful to treat aspects of age-related functional decline, age-related diseases that involve senescent cells, or side-effects of therapies that create senescent cells 36 .”
Self-citationAn Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Demaria, M., Ohtani, N., Youssef, S. A., Rodier, F., Toussaint, W., Mitchell, J. R., Laberge, R.-M., Vijg, J., Van Steeg, H., Dollé, M. E. T., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.11.012 · Cited by 2,045
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Physiology of Local Renin-Angiotensin Systems
Paul, M., Poyan Mehr, A., & Kreutz, R. (2006) · Physiological Reviews · doi:10.1152/physrev.00036.2005 · Cited by 1,739 · cited 1×
“Angiotensin receptor blockers attenuate age-related glomerulosclerosis under normotensive conditions, which has led to the idea that overactivation of the local renin-angiotensin-aldosterone system (RAAS) drives the formation of sclerotic glomeruli 31, 32 .”
Programmed cell senescence during mammalian embryonic development
Muñoz-Espín, D., Cañamero, M., Maraver, A., Gómez-López, G., Contreras, J., Murillo-Cuesta, S., Rodríguez-Baeza, A., Varela-Nieto, I., Ruberte, J., Collado, M., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.019 · Cited by 1,428
Senescence is a developmental mechanism that contributes to embryonic growth and patterning
Storer, M., Mas, A., Robert-Moreno, A., Pecoraro, M., Ortells, M. C., Di Giacomo, V., Yosef, R., Pilpel, N., Krizhanovsky, V., Sharpe, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.041 · Cited by 1,186 · cited 1×
“Furthermore, recent studies showing that senescent cells have beneficial effects in injury repair and tissue remodelling 6–10 have called into question the simplistic view of senescence as only a driver of age-dependent pathologies, raising the specter that senescent cell clearance might remove…”
Forging a signature of in vivo senescence
Sharpless, N. E., & Sherr, C. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3960 · Cited by 1,104 · cited 1×
“ATTAC was also not induced in peripheral blood T lymphocytes that robustly engage endogenous p16 Ink4a with aging without concomitant expression of multiple senescence markers 2, 13 (Extended Data Fig.”
Research works printed but not linked: 2
- 38. Baker DJ, et al. Increased expression of BubR1 protects against aneuploidy and cancer and extends healthy lifespan. Nat Cell Biol. 2012; 15:96-102. [PubMed: 23242215] · DOI · Paper page
- 48. Baker DJ, et al. BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nature genetics. 2004; 36:744-749. [PubMed: 15208629] · DOI · Paper page
Cited by
Items 2,001–2,100 of 2,883
Hyperglutaminolysis drives senescence and aging through arginine-mTORC1 axis activation
Chen, H., Huang, N., Xu, W., Yang, Y., Wang, F., Gong, H., Zhou, J., Tai, H., Zhao, T., Zhang, J., et al. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02576-w · Cited by 8
“1,2,4,5 11 However, many gaps remain on our way to make clear the mechanism underlying the aging-related metabolic dysregulation, which largely hinder the geriatric research and the development of human health.”
Targeting senescent microglia in progressive multiple sclerosis: a geroscience-informed approach
Atkinson, J., Dokiburra, A., Groover, H., Godbout, J. P., Segal, B. M., & Zhang, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1681724 · Cited by 7
“Together, D+Q act synergistically to eliminate a broader range of senescent cells than either agent alone (38), leading to improved lifespan in preclinical studies in mice (39).”
Abdellaoui, S., & Katsimpardi, L. (2025) · Aging Brain · doi:10.1016/j.nbas.2025.100144 · Cited by 6
The Role of Systemic Filtrating Organs in Aging and Their Potential in Rejuvenation Strategies
Kassab, A., Rizk, N. M., & Prakash, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084338 · Cited by 5
Bloemberg, D., & Quadrilatero, J. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30079 · Cited by 5
Cox, L. S. (2022) · The Journal of the Economics of Ageing · doi:10.1016/j.jeoa.2022.100423 · Cited by 8
The impact of cellular senescence on aging skeletal muscle
Kamal, M. J., Bevington, R. T., Johnson, A., & Parise, G. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1719279 · Cited by 8
Towards restoring proper chromosome segregation and preventing ageing
Tovini, L., & McClelland, S. E. (2020) · EMBO Reports · doi:10.15252/embr.202050322 · Cited by 4
The potential of flavonoids to mitigate cellular senescence in cardiovascular disease
Zheng, H., Li, T., Hu, Z., Zheng, Q., & Wang, J. (2024) · Biogerontology · doi:10.1007/s10522-024-10141-7 · Cited by 6
“Mechanisms by which cellular senescence affects CVD Cellular senescence may be of significance in the age-associated CVD, and p16-positive cells have been reported to be an engine that drives the cardiac senescence, causing a shorter longevity in aged mice (Baker et al. 2016).”
Peng, K., Xie, J., Xu, T., Chen, M., Guo, Y., Wang, Y., Qiu, H., Wu, D., Zeng, Z., Chen, S., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1302356 · Cited by 6
“The elimination of senescent cells can delay multiple age-related symptoms, and reduce incidences of spontaneous tumorigenesis and cancer-related mortality (23).”
BackgroundDeng, Y., He, X., Peng, J., Pan, Y., Luo, Y., Ruan, Y., Hou, J., Jiang, B., Li, X., Liang, X., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08007-y · Cited by 8
Mini review: Gene therapy targets for aging-associated diseases
Shchukina, E., Eremin, I. I., Mazunin, I., & Alexey, M. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152708 · Cited by 6
Tang, W., Zhang, Q., Qin, L., Yang, X., Chu, D., Li, H., Zhang, J., Zhang, Y., & Zhang, H. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157089 · Cited by 5
Cabral, J. E., Lackner, A., Jiang, W., Lin, S., Zhou, H., Wu, A., Demos, C., Pham, M. A., & McNulty, R. (2026) · Communications Biology · doi:10.1038/s42003-025-09501-x · Cited by 8
Does Joint Injury Make Young Joints Old?
Diekman, B. O., Collins, J. A., & Loeser, R. F. (2018) · Journal of the American Academy of Orthopaedic Surgeons · doi:10.5435/jaaos-d-18-00394 · Cited by 6
Immune therapeutic strategies for the senescent tumor microenvironment
Yasuda, T., & Wang, Y. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02865-7 · Cited by 10
Senescence-related signatures predict prognosis and response to immunotherapy in colon cancer
Hu, X., Zhu, X., Chen, Y., Zhang, W., Li, L., Liang, H., Байматович, У. Б., Donadon, M., Yusupbekov, A., & Zheng, Y. (2024) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-24-339 · Cited by 5
“However, multiple experiments have shown that aging cancer cells have different proliferative signals and can avoid apoptosis, induce angiogenesis, stimulate invasion and metastasis, and inhibit tumor immunity (9-12).”
Hautalterung – zelluläre Seneszenz: Wohin geht die Reise?
Scharffetter‐Kochanek, K., Wang, Y., Makrantonaki, E., Crișan, D., Wlaschek, M., Geiger, H., & Maity, P. (2023) · Die Dermatologie · doi:10.1007/s00105-023-05201-x · Cited by 5
Senescence as a therapeutic target
Meyer, K. R., Lopez-Dominguez, J. A., Maus, M., Kovatcheva, M., & Serrano, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822514-1.00014-6 · Cited by 6
Borges, G. Á., Diaz‐delCastillo, M., Guilatco, A. J., El-Masri, B. M., Mustapha, F., Gundesen, M. T., Hinge, M., Lund, T., Abdallah, N. H., Baughn, L. B., et al. (2025) · Leukemia · doi:10.1038/s41375-025-02572-z · Cited by 6
SATB1, senescence and senescence‐related diseases
Qi, W., Bai, J., Wang, R., Zeng, X., & Zhang, L. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31327 · Cited by 6
Finding Shangri-La: Limiting the Impact of Senescence on Aging
Trabucco, S. E., & Zhang, H. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.02.002 · Cited by 5
Impact of Aging and Cellular Senescence in the Pathophysiology of Preeclampsia
Suvakov, S. R., Kattah, A. G., Gojković, T., Enninga, E. A. L., Pruett, J. E., Jayachandran, M., Sousa, C., Santos, J., Hassan, C. A., Suarez, M. L. G., et al. (2023) · Comprehensive physiology · doi:10.1002/cphy.c230003 · Cited by 6
“In an animal model where p-16 positive senescent cells were ablated, age-related glomeru-losclerosis was reduced, and mice showed better kidney health (23).”
Ligand-specific regulation of a binary enhancer code dictating cellular senescence
Suter, T., Friedman, M. J., Tazearslan, C., Merkurjev, D., Ohgi, K., Meluzzi, D., Rosenfeld, M. G., & Suh, Y. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2506321122 · Cited by 5
Mehmood, A., Xue, Y., Yassin, H. M., Zubair, M. A., Rahmat, S. A., & Ahmad, A. (2025) · Współczesna Onkologia · doi:10.5114/wo.2025.152369 · Cited by 16
“In opposing a number of aging phenotypes, including skeletal muscle atrophy [47], glomerulosclerosis of the kidney [48], and macrophage infiltration of tissues (a characteristic of chronic inflammation [45, 49]), thus longer-term treatments (20–26 months) can be successful.”
Gene purging and the evolution of Neoave metabolism and longevity
Ng, D. W. J., Pawling, J., & Dennis, J. W. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105409 · Cited by 6
“Targeted elimination of these p16 + cells in mice increases lifespan and prolongs physical vitality (50).”
Backgroundγδ T Cells Target and Ablate Senescent Cells in Aging and Alleviate Pulmonary FibrosisPreprint
Meca-Laguna, G., Admasu, T. D., Shankar, A., Barkovskaya, A., Collibee, I., Krakauer, A. A., Tran, T., Rae, M. J., & Sharma, A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.05.652251 · Cited by 8
Targeting Alternative Splicing for Reversal of Cellular Senescence in the Context of Aesthetic Aging
Bramwell, L. R., & Harries, L. W. (2020) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000007618 · Cited by 6
Bramwell, L. R., Frankum, R., & Harries, L. W. (2024) · Cells · doi:10.3390/cells13060517 · Cited by 4
Guo, R., Wu, Z., Lu, M., Li, J., Li, W., Yue, B., Ding, S., Li, C., & Zhou, G. (2025) · Food Materials Research · doi:10.48130/fmr-0025-0006 · Cited by 10
Cellular Senescence in Acute Liver Injury: What Happens to the Young Liver?
He, K., Zhou, D., Pu, Z., Chen, S., Shen, Y., Zhao, S., Qian, X., Hu, Q., Wu, X., Xie, Z., et al. (2024) · Aging and Disease · doi:10.14336/ad.2024.0586 · Cited by 8
“It contributes to aging [8], age-related tissue dysfunction [9], chronic diseases [10], tissue fibrosis [11], tumor promotion [12], immune deficits, and stem cell exhaustion [13].”
Amram, S., Iram, T., Lazdon, E., Vassar, R. J., Ben‐Porath, I., & Frenkel, D. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/700013 · Cited by 10
Klotho protects INS-1 pancreatic β-cells from senescence and enhances mitochondrial function
Wang, Z., Ni, Y., Lou, Y., Prud’homme, G. J., & Wang, Q. (2025) · Frontiers in Aging · doi:10.3389/fragi.2025.1512322 · Cited by 6
Shanker, P. R., & Dorajoo, R. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27031613 · Cited by 5
“Animal model studies have demonstrated that increased stress induces senescence markers, such as p16INK4a, in the hippocampus [67–72] (Table 1).”
Identification of lipid senolytics targeting senescent cells through ferroptosis inductionPreprint
Zhang, L. J., Salekeen, R., Soto-Palma, C., Elsallabi, O., Ye, H., Hughes, B., Zhang, B., Nunes, A., Lee, K., Xu, W., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.14.618023 · Cited by 5
Nakano, Y., & Johmura, Y. (2025) · The Journal of Biochemistry · doi:10.1093/jb/mvae098 · Cited by 9
Fluoride induced down-regulation of IKBKG Gene expression inhibits hepatocytes senescence
Wu, C., Mao, C. Y., Deng, J. V., Zhang, T., Zhao, Y., Guan, Z., Hu, X., & Qi, X. (2021) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2021.126896 · Cited by 5
Mitochondrial double-stranded RNA drives aging-associated cognitive decline
Zhang, L., Li, X., Luo, H., Huo, Y., Zhou, G., Wang, P., Wu, S., Lin, X., Dai, K., Shi, J., et al. (2026) · Cell Research · doi:10.1038/s41422-026-01224-w · Cited by 7
Nurkolis, F., Utami, T. W., Alatas, A. I., Wicaksono, D., Kurniawan, R., Ratmandhika, S. R., Sukarno, K. T., Pahu, Y. G. P., Kim, B., Tallei, T. E., et al. (2024) · Frontiers in Aging · doi:10.3389/fragi.2024.1462569 · Cited by 6
“Thin endometrium” at single-cell resolution
Zhang, X., Lv, H., Weng, Q., Jiang, P., Dai, C., Zhao, G., & Hu, Y. (2025) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2024.10.002 · Cited by 8
Kelsey, M. M. G., Dalgarno, A., Evans, S. A., Nuñez, T. A., Rocha, A. V., Clark, K., Sedivy, J. M., & Neretti, N. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.11.659151 · Cited by 7
“Studies in mice have also indicated that the clearance of senescent cells can extend lifespan and healthspan 7,8 .”
Procyanidin C1 is a natural agent with senolytic activity against aging and age-related diseasesPreprint
Xu, Q., Fu, Q., Li, Z., Liu, H., Wang, Y., Lin, X., He, R., Zhang, X., Campisi, J., Kirkland, J. L., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.14.439765 · Cited by 7
Metabolism and metabolomics in senescence, aging, and age-related diseases: a multiscale perspective
Wang, Z., Zhu, H., & Xiong, W. (2025) · Frontiers of Medicine · doi:10.1007/s11684-024-1116-0 · Cited by 7
Modeling of senescent cell dynamics predicts a late‐life decrease in cancer incidence
Bieuville, M., Tissot, T., Robert, A., Henry, P., & Pavard, S. (2023) · Evolutionary Applications · doi:10.1111/eva.13514 · Cited by 5
“It would be interesting to reiterate senolytic experiments with the same modified mice model as previously described (Baker et al., 2016) F I G U R E 5 Percentage change in the cumulative incidence of (a) cancer and (b) ageing- related causes after senolysis. to assess whether this is the same in…”
BackgroundInfluentialDietary restriction in senolysis and prevention and treatment of disease
Aminzadeh-Gohari, S., Kofler, B., & Herzog, C. M. S. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2153355 · Cited by 6
“Consistent with this, removal of senescent cells has been shown to increase lifespan and delay onset of age-associated diseases, including cancer, in various mouse models (Baker et al. 2011; Baker et al. 2016; Demaria et al. 2014).”
Zhang, M., Li, L., Zhang, W., Li, M., Yan, G., & Tang, C. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111296 · Cited by 6
Cellular senescence as a source of chronic microinflammation that promotes the aging process
Nakanishi, M. (2025) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.101.014 · Cited by 5
Sorokina, A. G., Orlova, Y. A., Grigorieva, O., Novoseletskaya, E. S., Basalova, N. A., Alexandrushkina, N. A., Vigovskiy, M. A., Kirillova, K. I., Balatsky, A. V., Samokhodskaya, L. M., et al. (2022) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2021-3051 · Cited by 5
Gijsen, H. S. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-55035-6_16 · Cited by 6
Cai, X., Cui, Y.-Y., Ding, C.-Y., Liu, H.-B., Yu, M., Chen, L.-Y., Ding, C.-Y., Wu, X., Zhang, H., Li, C., et al. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123747 · Cited by 12
Ambrosino, A., Patrone, D., Moriello, C., Sammarraie, S. H. A. A., Lettiero, I., Finicelli, M., Siniscalco, D., & Alessio, N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26189134 · Cited by 5
“However, we did not directly assess SASP modulation, and further studies will be required to evaluate potential senomorphic effects [28].”
Fucoidans are senotherapeutics that enhance SIRT6-dependent DNA repairPreprint
Robbins, P. D., Zhang, L. J., Elsallabi, O., Soto-Palma, C., Bartz, J., Salekeen, R., Nunes, A., Xu, W., Lee, K., Hughes, B., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-6613032/v1 · Cited by 8
Optimal intercellular competition in senescence and cancer
Michaels, T. C. T., & Mahadevan, L. (2023) · Proceedings of the Royal Society A Mathematical Physical and Engineering Sciences · doi:10.1098/rspa.2023.0204 · Cited by 4
INDUCTION OF EARLY PULMONARY SENESCENCE IN EXPERIMENTAL SEPSIS
Mösenlechner, M., Schlösser, D., Braumüller, S. T., Dörfer, L., Mannes, M., Kawach, R., Strauß, G., Schmidt, C. Q., Lupu, L., & Huber-Lang, M. S. (2024) · Shock · doi:10.1097/shk.0000000000002512 · Cited by 6
Sesamin Metabolites Suppress the Induction of Cellular Senescence
Araki, C., Takemoto, D., Kitagawa, Y., Tateishi, N., Rogi, T., Izumo, T., Kawamoto, S., Shibata, H., Hara, E., & Nakai, M. (2023) · Nutrients · doi:10.3390/nu15071627 · Cited by 8
Genetics of aging and longevity
Moskalev, A., Proshkina, E., Belyi, A. A., & Solovev, I. A. (2016) · Vavilov Journal of Genetics and Breeding · doi:10.18699/vj16.171 · Cited by 8
Ezcurra, M., Benedetto, A., Sornda, T., Gilliat, A. F., Au, C., Zhang, Q., van Schelt, S., Petrache, A. L., de la Guardia, Y., Bar‐Nun, S., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/234419 · Cited by 5
Drug Delivery Strategies for Age-Related Diseases
Yoshihara, K., & Horiguchi, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168693 · Cited by 5
Wang, R., Chan, S. Y., & Finkel, T. (2026) · Circulation · doi:10.1161/circulationaha.125.075567 · Cited by 11
An Unbiased Cell‐Culture Selection Yields DNA Aptamers as Novel Senescent Cell‐Specific Reagents
Pearson, K. S., Jachim, S. K., Doherty, C. L., Wilbanks, B. A., Prieto, L. I., Dugan, M. B., Baker, D. J., LeBrasseur, N. K., & Maher, L. J., III (2025) · Aging Cell · doi:10.1111/acel.70245 · Cited by 4
Self-citationAging affects ciliated cells development in the human endometrial epitheliumPreprint
Loid, M., Obukhova, D., Kask, K., Meltsov, A., Derks, K., Altmäe, S., Saare, M., Peters, M., Minajeva, A., Adler, P., et al. (2023) · medRxiv · doi:10.1101/2023.05.22.23290333 · Cited by 4
Barinda, A. J., Arozal, W., & Yuasa, S. (2022) · Medical Journal of Indonesia · doi:10.13181/mji.rev.226064 · Cited by 4
Senescent cells and the dynamics of agingPreprint
Karin, O., Agrawal, A., Porat, Z., Krizhanovsky, V., & Alon, U. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/470500 · Cited by 4
Cellular senescence: mechanisms and clinical implications
Михайловна, М. А., Pashenkov, M. V., & Pinegin, B. V. (2024) · Immunologiya · doi:10.33029/1816-2134-2024-45-2-221-234 · Cited by 11
Srour, E., Martin, N., Drullion, C., de Schutter, C., Giroud, J., Pioger, A., Deslé, J., Saas, L., Nassour, J., Théry, J., et al. (2024) · Aging · doi:10.18632/aging.206149 · Cited by 7
Accelerated Aging in Bone Marrow Transplant Survivors
Skinner, R., & von Zglinicki, T. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.0877 · Cited by 4
Novel Probes and Carriers to Target Senescent Cells
Lozano‐Torres, B., Blandez, J. F., Sancenón, F., & Martínez‐Máñez, R. (2020) · Healthy ageing and longevity · doi:10.1007/978-3-030-44903-2_9 · Cited by 4
Thomann, S., Tóth, M., Sprengel, S. D., Liermann, J., & Schirmacher, P. (2022) · Journal of Histochemistry & Cytochemistry · doi:10.1369/00221554221112701 · Cited by 6
Palazzo, A., Makulyte, G., Goerhig, D., Médard, J., Gros, V., Trottein, F., Adnot, S., Vindrieux, D., Flaman, J., & Bernard, D. (2023) · Aging · doi:10.18632/aging.205259 · Cited by 4
Extension of Life Span in Laboratory Mice
Unnikrishnan, A., Deepa, S. S., Herd, H. R., & Richardson, A. G. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811353-0.00019-1 · Cited by 8
Majeed, Y., Madani, A. Y., Altamimi, A. I., Courjaret, R. J., Vakayil, M., Fountain, S. J., Machaca, K., & Mazloum, N. A. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15978 · Cited by 4
Immunosuppressive macrophages determine the effect of cellular senescence on tumor progression
Lalinde-Gutiérrez, M., Pérez‐Ramos, S., Rodilla, V., Garcia-Baucells, P., Julia, P.-B., Berenguer‐Molins, P., Nonell, L., Agustí-Barea, I., Mueller, C. G., & Arribas, J. (2026) · Science Advances · doi:10.1126/sciadv.adx2988 · Cited by 4
“Nevertheless, p16-driven models have shown that eliminating senescent cells can extend lifespan and reduce frailty associated with aging or chemotherapy ( 17 ).”
Role of Prion protein in premature senescence of human fibroblasts
Boilan, E., Winant, V., Dumortier, E., Elmoualij, B., Quatresooz, P., Osiewacz, H. D., Debacq‐Chainiaux, F., & Toussaint, O. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.08.002 · Cited by 5
3-Deazaadenosine keeps senescence at bay
Guerrero, A. T. G., & Gil, J. (2023) · Aging · doi:10.18632/aging.204625 · Cited by 5
Life and death rest on a bivalent chromatin state
Yang, X. (2016) · Nature Neuroscience · doi:10.1038/nn.4396 · Cited by 4
Deryabin, P. I., & Бородкина, А. В. (2021) · Cell and Tissue Biology · doi:10.1134/s1990519x2106002x · Cited by 5
Almeida, M., & Manolagas, S. C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00012-9 · Cited by 7
Aging skin and non-surgical procedures: a basic science overview
Vandiver, A. R., & Hogan, S. R. (2020) · Plastic and Aesthetic Research · doi:10.20517/2347-9264.2020.159 · Cited by 10
Hou, Q., Liu, R., Yang, X., & Zhang, B. (2025) · Journal of Integrative Agriculture · doi:10.1016/j.jia.2025.08.002 · Cited by 4
The roles of cell cycle proteins in regulating the tumor immune microenvironment
Zhu, Q., Wei, X., Qu, Z., Lu, L., Zhang, Y., & Wang, H. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101706 · Cited by 9
Kühnel, H., Pasztorek, M., Kuten-Pella, O., Kramer, K., Bauer, C., Lacza, Z., & Nehrer, S. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46030122 · Cited by 4
“Cellular senescence has emerged as a significant contributor to age-related degenerative diseases [1,2].”
BackgroundSenescence diversity in muscle aging
Durik, M., & Keyes, W. M. (2022) · Nature Aging · doi:10.1038/s43587-022-00255-3 · Cited by 4
Self-citationDevelopment of novel flavonoid senolytics through phenotypic drug screening and drug designPreprint
Zhang, L. J., Salekeen, R., Soto-Palma, C., He, Y., Elsallabi, O., Hughes, B., Nunes, A., Xu, W., Zhang, B., Mohamed, A. D., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.27.620529 · Cited by 4
Giroud, J., Combémorel, E., Pourtier, A., Abbadie, C., & Pluquet, O. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00091.2025 · Cited by 10
Fueling the fire: metabolic dysfunction and senescence as drivers of lung aging and disease
Kliment, C. R., Gurkar, A. U., Cárdenes, N., Ramonell, R. P., Finkel, T., & Königshoff, M. (2026) · Physiological Reviews · doi:10.1152/physrev.00024.2025 · Cited by 7
Is Human Aging a Form of Phenoptosis?
Libertini, G., Corbi, G., Shubernetskaya, O. S., & Ferrara, N. (2022) · Biochemistry (Moscow) · doi:10.1134/s0006297922120033 · Cited by 5
He, Y., Long, K., Du, B., Liao, W., Zou, R., Su, J., Luo, J., Shi, Z., & Wang, L. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150576 · Cited by 7
A ganglioside-based senescence-associated immune checkpointPreprint
Iltis, C., Seguin, L., Cervera, L., Duret, L. C., Hamidouche, T., Kunz, S., Croce, O., Delannoy, C. P., Guérardel, Y., Allain, F., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.23.440408 · Cited by 4
Emerging concepts in drug discovery for cancer therapy
Murga, M., & Fernández-Capetillo, Ó. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13325 · Cited by 4
Takemoto, K., Ozaki, A., Tanii, Y., Yagi, M., Ichihashi, M., & Ando, H. (2025) · Antioxidants · doi:10.3390/antiox14121437 · Cited by 4
“Removing senescent cells in mice delayed tumor formation and suppressed age-related degeneration in multiple organs, including the kidneys, heart, and adipose tissue [44].”
Senescence of endplate osteoclasts induces sensory innervation and spinal pain
Pan, D., Benkato, K. G., Han, X., Zheng, J., Kumar, V., Wan, M., Zheng, J., & Cao, X. (2024) · eLife · doi:10.7554/elife.92889 · Cited by 26
Natural Product-Derived Senotherapeutics: Extraction and Biological Evaluation Techniques
Pratsinis, H., Mavrogonatou, E., Zervou, S., Triantis, T. M., Hiskia, A. E., & Kletsas, D. (2025) · Methods in molecular biology · doi:10.1007/978-1-0716-4426-3_19 · Cited by 4
Yu, X., Lobo, J. D., Sundermann, E. E., Baker, D. J., Tracy, R. P., Kuchel, G. A., Stephenson, K. E., Letendre, S. L., Brew, B. J., Cysique, L. A., et al. (2023) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2022.0079 · Cited by 7
“12 Our observation that senescent cells can be safely removed without causing negative effects, at least in laboratory mice, opened the possibility that influencing the accumulation of senescent cells may impact various diseases of aging.”
Self-citationStarich, B., Yang, F., Tanrioven, D., Kung, H., Baek, J., Nair, P. R., Kamat, P., Macaluso, N. C., Eoh, J. H., Han, K. S., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.06.579151 · Cited by 7
“Recent findings from animal models and clinical trials in humans have shown that the depletion of senescent cells mitigates various aging-related dysfunctions and influences tissue regeneration and repair 6,7 .”
BackgroundBonaroti, J. W., Ozel, M., Chen, T., Darby, J. L., Sun, X., Moheimani, H., Reitz, K. M., Kar, U. K., Zuckerbraun, B. S., Das, J., et al. (2023) · Journal of the American College of Surgeons · doi:10.1097/xcs.0000000000000922 · Cited by 5
Takaya, K., Asou, T., & Kishi, K. (2023) · Biogerontology · doi:10.1007/s10522-023-10043-0 · Cited by 4
Khan, T., McFall, D. J., Hussain, A. I., Frayser, L. A., Casilli, T. P., Steck, M. C., Sánchez-Brualla, I., Kuehn, N. M., Cho, M., Barnes, J. A., et al. (2025) · Annals of Neurology · doi:10.1002/ana.78118 · Cited by 5
“7,13,28,49,50 Genetic SC ablation reduced daily seizure burden without affecting the duration of the seizures themselves.”
Metadata
- Authors
- Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., Khazaie, K., Miller, J. D., & van Deursen, J. M.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Baker, Darren J.
- van Deursen, Jan M.
- ORCID
- Venue
- Nature
- Published
- 2016-02
- Volume
- 530
- Issue
- 7589
- Pages
- 184-189
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4845101
- OpenAlex
- W2266290735
- Cited by
- 2,876
- References
- 50
- Citations by year
- 2026: 254 · 2025: 253 · 2024: 318 · 2023: 298 · 2022: 305 · 2021: 286 · 2020: 312 · 2019: 279 · 2018: 236 · 2017: 210 · 2016: 123
- FWCI
- 116.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- National Institute on Aging (P01AG041122, R37AG013925)
- National Heart, Lung, and Blood Institute (R01HL111121)
- National Cancer Institute (R01CA166347, R01CA096985, P30CA015083)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- cellular senescence, p16INK4a, senolytics, healthspan, aging, senescent cell clearance, carcinogenesis, renal function, cardiac KATP channels, adipocytes, AP20187, CDKN2A
- MeSH terms
- Aging, Animals, Cell Separation, Cell Transformation, Neoplastic, Epithelial Cells, Female, Health, Kidney, Lipodystrophy, Longevity, Male, Myocardium, Organ Specificity, Stem Cells, Time Factors, Cellular Senescence, Apoptosis, Adipocytes, Cyclin-Dependent Kinase Inhibitor p16, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-29, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-29 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.